Rapidly progressive aphasic dementia with motor neuron disease: a distinctive clinical entity

Marco Catani1, Massimo Piccirilli, Maria Concetta Geloso

  • 1Institute of Psychiatry, London, UK. m.catani@iop.kcl.ac.uk

Insights

Motor neuron disease (MND) combined with rapidly progressive aphasic dementia is a distinct frontotemporal dementia (FTD) syndrome. Neuropathological findings in one case support this classification, showing unique brain changes.

Area of Science:

  • Neuroscience
  • Neuropathology
  • Clinical Neurology

Background:

  • Motor neuron disease (MND) and frontotemporal dementia (FTD) can co-occur as a distinct clinical syndrome.
  • Previous neuropathological studies on FTD-MND have yielded heterogeneous findings.
  • Understanding the specific neuropathology of FTD-MND is crucial for accurate diagnosis and classification.

Observation:

  • A case study of a 71-year-old male with rapidly progressive aphasic dementia and MND was investigated.
  • Initial findings included selective non-fluent aphasia and hypoperfusion in the left frontotemporal cortex.
  • Asymmetric brain metabolite changes were observed via proton magnetic resonance spectroscopy, predominantly in the left temporal lobe.

Findings:

  • The patient exhibited progressive bulbar manifestations of MND, followed by death from bronchopneumonia.
  • Neuropathological examination revealed neuronal loss in the hypoglossal nucleus and spinal cord anterior horns.
  • Distinctive frontoparietotemporal cortical changes included microvacuolation and ubiquitin-positive deposits, excluding Alzheimer's, Pick's, or Lewy body disease.

Implications:

  • These findings reinforce the classification of MND with rapidly progressive aphasic dementia as a unique clinical entity within FTD-MND.
  • This case contributes to defining the specific neuropathological signature of this syndrome.
  • Further research into FTD-MND is warranted to elucidate its distinct pathological mechanisms and clinical spectrum.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...